Related Experiment Video

Updated: Aug 13, 2025

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
07:51

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Published on: September 22, 2011

28.7K

mRNA Metabolism and Hypertension

Martina Zappa1, Paolo Verdecchia2,3, Antonio Spanevello1,4

  • 1Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.

Biomedicines
|January 21, 2023
PubMed

Insights

Hypertension affects 1.5 billion adults globally, with cases doubling in 30 years. Understanding messenger RNA (mRNA) metabolism offers new therapeutic targets for controlling high blood pressure.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Genetics

Background:

  • Hypertension is a primary global cardiovascular risk factor, affecting 1.5 billion adults in 2015.
  • The number of hypertensive patients aged 30-79 has doubled in 30 years, despite stable age-standardized prevalence.
  • Low rates of controlled hypertension highlight the need for novel therapeutic strategies.

Purpose of the Study:

  • To explore the role of messenger RNA (mRNA) metabolism in hypertension pathogenesis.
  • To investigate pharmacological modulation of RNA metabolism as a potential therapeutic approach for hypertension.

Main Methods:

  • Review of recent studies on mRNA metabolism and hypertension.
  • Analysis of epidemiological data on hypertension prevalence and control rates.
  • Exploration of emerging therapeutic strategies targeting RNA metabolism.

Main Results:

  • Alterations in mRNA metabolism are increasingly recognized as contributors to hypertension.
  • Pharmacological interventions targeting RNA metabolism are under investigation.
  • These novel approaches may offer new avenues for managing hypertension.

Conclusions:

  • Understanding mRNA metabolism is crucial for developing innovative hypertension treatments.
  • Targeting RNA metabolism presents a promising frontier in cardiovascular pharmacotherapy.
  • Further research into RNA-based therapies could significantly improve hypertension control worldwide.

Keywords:
blood pressurechronic diseasehypertensionmRNAmetabolism

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

825
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

608

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
31
Metabolic Rate01:25

Metabolic Rate

The human body is a powerhouse of energy, with every cell performing numerous functions that require energy. This energy production and consumption is measured by the metabolic rate, which quantifies the total heat generated by all the body's chemical reactions and mechanical work. This measurement helps to determine the rate of kilocalorie (kcal) consumption needed to fuel all ongoing activities.
The Basal Metabolic Rate (BMR) measures the energy expended at rest.
Several factors influence...
449
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
134
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
481